Home Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
 

Keywords :   


Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say

2015-03-05 00:53:04| Biotech - Topix.net

Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.

Tags: year say sell reports

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »